Lynparza Combo Approved for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
Lynparza is a poly polymerase inhibitor.
Transient clinically meaningful decline noted in EPIC hormonal and sexual domains with total androgen suppression added to radiation
Paxlovid has been taken by seniors and others at high risk for severe COVID-19 under an emergency use approval
Older Americans think they take too many medicines, and a sizable percentage said they have cut back
Declines seen in current smoking, physical inactivity, heavy alcohol consumption; increase seen in uptake of HPV vaccine, stool testing for CRC